Literature DB >> 23567275

Polycystic kidney disease: Polycystin-1 and polycystin-2--it's complicated.

Terry J Watnick1, Gregory G Germino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23567275     DOI： 10.1038/nrneph.2013.73

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

Review 1.  Molecular advances in autosomal dominant polycystic kidney disease.

Authors:  Anna Rachel Gallagher; Gregory G Germino; Stefan Somlo
Journal:  Adv Chronic Kidney Dis       Date:  2010-03       Impact factor: 3.620

2.  Constitutive activation of G-proteins by polycystin-1 is antagonized by polycystin-2.

Authors:  Patrick Delmas; Hideki Nomura; Xiaogang Li; Montaha Lakkis; Ying Luo; Yoav Segal; Jose M Fernández-Fernández; Peter Harris; Anna-Maria Frischauf; David A Brown; Jing Zhou
Journal:  J Biol Chem       Date:  2002-01-10       Impact factor: 5.157

3.  A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation.

Authors:  Sorin V Fedeles; Xin Tian; Anna-Rachel Gallagher; Michihiro Mitobe; Saori Nishio; Seung Hun Lee; Yiqiang Cai; Lin Geng; Craig M Crews; Stefan Somlo
Journal:  Nat Genet       Date:  2011-06-19       Impact factor: 38.330

4.  A human PKD1 transgene generates functional polycystin-1 in mice and is associated with a cystic phenotype.

Authors:  L Pritchard; J A Sloane-Stanley; J A Sharpe; R Aspinwall; W Lu; V Buckle; L Strmecki; D Walker; C J Ward; C E Alpers; J Zhou; W G Wood; P C Harris
Journal:  Hum Mol Genet       Date:  2000-11-01       Impact factor: 6.150

5.  cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells.

Authors:  Kazushige Hanaoka; William B Guggino
Journal:  J Am Soc Nephrol       Date:  2000-07       Impact factor: 10.121

6.  cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway.

Authors:  T Yamaguchi; J C Pelling; N T Ramaswamy; J W Eppler; D P Wallace; S Nagao; L A Rome; L P Sullivan; J J Grantham
Journal:  Kidney Int       Date:  2000-04       Impact factor: 10.612

7.  Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist.

Authors:  Vincent H Gattone; Xiaofang Wang; Peter C Harris; Vicente E Torres
Journal:  Nat Med       Date:  2003-09-21       Impact factor: 53.440

8.  Polycystin-1 and -2 dosage regulates pressure sensing.

Authors:  Reza Sharif-Naeini; Joost H A Folgering; Delphine Bichet; Fabrice Duprat; Inger Lauritzen; Malika Arhatte; Martine Jodar; Alexandra Dedman; Franck C Chatelain; Uwe Schulte; Kevin Retailleau; Laurent Loufrani; Amanda Patel; Frederick Sachs; Patrick Delmas; Dorien J M Peters; Eric Honoré
Journal:  Cell       Date:  2009-10-30       Impact factor: 41.582

9.  Hyperphosphorylation of polycystin-2 at a critical residue in disease reveals an essential role for polycystin-1-regulated dephosphorylation.

Authors:  Andrew J Streets; Oliver Wessely; Dorien J M Peters; Albert C M Ong
Journal:  Hum Mol Genet       Date:  2013-02-05       Impact factor: 6.150

10.  Aurora A kinase activity influences calcium signaling in kidney cells.

Authors:  Olga V Plotnikova; Elena N Pugacheva; Erica A Golemis
Journal:  J Cell Biol       Date:  2011-06-13       Impact factor: 10.539
  10 in total
  5 in total

Review 1.  Systems biology of polycystic kidney disease: a critical review.

Authors:  Luis Fernando Menezes; Gregory G Germino
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2015-02-02

2.  Human polycystin-2 transgene dose-dependently rescues ADPKD phenotypes in Pkd2 mutant mice.

Authors:  Ao Li; Xin Tian; Xiaoli Zhang; Shunwei Huang; Yujie Ma; Dianqing Wu; Gilbert Moeckel; Stefan Somlo; Guanqing Wu
Journal:  Am J Pathol       Date:  2015-10       Impact factor: 4.307

3.  Use of mammalian target of rapamycin inhibitors in patient with autosomal dominant polycystic kidney disease: an updated meta-analysis.

Authors:  Chun-Hung Lin; Chia-Ter Chao; Mei-Yi Wu; Wei-Cheng Lo; Tsu-Chen Lin; Mai-Szu Wu
Journal:  Int Urol Nephrol       Date:  2019-10-01       Impact factor: 2.370

Review 4.  Tissue-engineered kidney disease models.

Authors:  Teresa M Desrochers; Erica Palma; David L Kaplan
Journal:  Adv Drug Deliv Rev       Date:  2013-12-17       Impact factor: 15.470

5.  Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1/cyclin axis.

Authors:  Ao Li; Song Fan; Yuchen Xu; Jialin Meng; Xufeng Shen; Jun Mao; Li Zhang; Xiansheng Zhang; Gilbert Moeckel; Dianqing Wu; Guanqing Wu; Chaozhao Liang
Journal:  J Cell Mol Med       Date:  2017-02-28       Impact factor: 5.310
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.